查看購物車
  • English
  • Japanese
  • Korean
數位PCR市場－全球及區域分析：聚焦產品、應用、終端使用者及區域分析－分析及預測期：2026-2036年
市場調查報告書
商品編碼
2087978

數位PCR市場－全球及區域分析：聚焦產品、應用、終端使用者及區域分析－分析及預測期：2026-2036年

Digital PCR Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Regional Analysis - Analysis and Forecast Year, 2026-2036
出版日期: | 出版商: BIS Research | 英文 199 Pages | 商品交期: 1-5個工作天內

價格

全球數位PCR市場產業概覽

2024 年全球數位 PCR 市場價值 7.819 億美元，預計從 2026 年到 2036 年將以 15.52% 的複合年成長率顯著成長，到 2036 年達到 44.089 億美元。

關鍵市場統計數據
預測期 2026-2036
2026 年市場規模 1,041,400,000 美元
2036年的預測 4.489億美元
複合年成長率 15.52%

全球數位PCR市場預計將穩定成長，這主要得益於研究、臨床、轉化和應用檢測領域對高靈敏度、高精度核酸絕對定量分析需求的不斷成長。數位聚合酵素鏈鎖反應（數位PCR）可將檢體分割成數千至數百萬個獨立的反應，因此無需依賴標準曲線即可精確檢測和定量低濃度目標物質。因此，該技術在罕見突變檢測、拷貝數變異分析、微量殘存疾病監測、病毒量定量、基因表現分析、移植監測、食品安全檢測、環境檢測和生物製藥研究等領域具有廣泛的應用前景。

數位PCR技術的發展日益著重於提高檢測靈敏度、多重分析能力、處理能力、自動化程度、工作流程效率以及基於軟體的結果解讀。基於液滴的系統、基於晶片的平台、整合的分段式工作流程、檢驗的檢測組合以及高通量儀器正在幫助檢查室提高複雜分子檢測工作流程的可重複性並降低變異性。此外，數位PCR與次世代定序、液態生物檢體工作流程和先進分子檢測的互補應用，正在增強其在精準診斷、轉化研究和生物製藥開發中的作用。

市場概覽

數位PCR在臨床診斷、轉化研究、生物製藥開發、環境檢測以及其他需要精確定量低濃度核酸標靶的特殊分子應用中變得至關重要。它無需外部標準曲線即可進行絕對定量，這一優勢推動了其在分析靈敏度、重複性和可靠檢測罕見分子事件至關重要的工作流程中的應用。

從市場角度來看，對可靠分子檢測方法日益成長的需求，以及數位PCR技術在專業調查、診斷和品管工作流程中日益廣泛的應用，正在推動其普及。隨著檢測範圍的擴大、平台自動化程度的提高以及易用性的增強，數位PCR有望進一步鞏固其在更廣泛的分子檢測生態系統中作為補充技術的地位。

對產業的影響

數位PCR技術透過提供更可靠的定量測量，增強了分子檢測生態系統，尤其是在目標濃度低、樣本背景複雜以及濃度差異極小等傳統方法難以應對的應用場景中。其日益廣泛的應用有助於提高專業調查、檢測和品管工作流程中的分析可靠性和可重複性。

在產業層面，數位PCR技術的日益普及推動了對標準化檢測方法、穩定的耗材供應、檢驗的工作流程以及可互通的數據分析的需求。這正逐步拓展該技術的應用範圍，使其從專業研究擴展到更廣泛的轉化研究、生物製藥以及能夠提供清晰分析價值的特定臨床應用領域。

目錄

第1章：全球數位PCR市場：產業展望

  • 市場概覽與生態系統
    • 數位PCR工作流程
    • qPCR 和 dPCR 的比較
    • 技術藍圖與演進
    • 實施狀況和採用率分析
    • 數位PCR在細胞和基因治療的應用
    • 資金籌措和投資趨勢
    • 趨勢：對當前和未來影響的評估
    • 供應鏈分析
    • 價格分析
    • 專利分析
    • 正在進行中的數位PCR臨床試驗
    • 監理情勢
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇

第2章 全球數位PCR市場（依產品分類），百萬美元，2024-2036年

  • 系統
    • 概述
    • 市場規模及預測
  • 耗材（試劑盒、檢測方法、試劑）
  • 軟體和服務

第3章 全球數位PCR市場（按應用領域分類），百萬美元，2024-2036年

  • 臨床和研究應用
    • 概述
    • 市場規模及預測
  • 環境領域的應用
  • 法醫學應用
  • 其他用途

第4章 全球數位PCR市場（按最終用戶分類），百萬美元，2024-2036年

  • 學術和研究機構
  • 醫院和診所
  • 診斷中心
  • 製藥和生物製藥公司
  • 其他最終用戶

第5章：全球數位PCR市場（按地區分類），百萬美元，2024-2036年

  • 區域概況
  • 北美洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 分析師意見
    • 市場規模及預測
  • 歐洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 分析師意見
    • 市場規模及預測
  • 亞太地區
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 分析師意見
    • 市場規模及預測
  • 拉丁美洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 分析師意見
    • 市場規模及預測
  • 中東和非洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 分析師意見
    • 市場規模及預測

第6章：競爭標竿分析與公司概況

  • 關鍵策略和趨勢
    • 併購
    • 合作夥伴關係、聯盟和業務拓展
    • 新產品和服務
  • 公司簡介
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck KGaA
    • QIAGEN NV
    • Thermo Fisher Scientific Inc.
    • Genetron Holdings Limited
    • Precigenome LLC
    • RevoSketch Inc.
    • JN Medsys
    • JETA Molecular BV.
    • Sysmex Corporation
    • TargetingOne Corporation
    • RainSure Scientific
    • Pilot Gene Technology（Hangzhou）Co., Ltd.

第7章：調查方法

Product Code: BHP0944SD

This report can be delivered within 1 working day.

Global Digital PCR Market Industry Overview

The global digital PCR market, valued at $781.9 million in 2024, is projected to grow substantially, reaching $4,408.9 million by 2036, with a compound annual growth rate (CAGR) of 15.52% from 2026 to 2036.

KEY MARKET STATISTICS
Forecast Period2026 - 2036
2026 Evaluation$1,041.4 Million
2036 Forecast$4,408.9 Million
CAGR15.52%

The global digital PCR market is expected to grow steadily, supported by increasing demand for highly sensitive, precise, and absolute quantification of nucleic acids across research, clinical, translational, and applied testing settings. Digital polymerase chain reaction enables partitioning of samples into thousands to millions of individual reactions, allowing accurate detection and quantification of low-abundance targets without relying on standard curves. This makes the technology particularly useful for rare mutation detection, copy number variation analysis, minimal residual disease monitoring, viral load quantification, gene expression analysis, transplant monitoring, food safety testing, environmental testing, and biopharmaceutical research.

Technology development in digital PCR is increasingly focused on improving assay sensitivity, multiplexing, throughput, automation, workflow efficiency, and software-enabled interpretation. Droplet-based systems, chip-based platforms, integrated partitioning workflows, validated assay panels, and higher-throughput instruments are helping laboratories improve reproducibility and reduce variability in complex molecular testing workflows. In addition, the complementary use of digital PCR with next-generation sequencing, liquid biopsy workflows, and advanced molecular testing is strengthening its role in precision diagnostics, translational research, and biopharmaceutical development.

Market Introduction

Digital PCR has gained significant relevance in clinical diagnostics, translational research, biopharmaceutical development, environmental testing, and other specialized molecular applications that require precise quantification of low-abundance nucleic acid targets. Its ability to provide absolute quantification without external standard curves supports its use in workflows where analytical sensitivity, reproducibility, and reliable detection of rare molecular events are important.

From a market perspective, adoption is being supported by growing demand for high-confidence molecular measurements and increasing integration of digital PCR into specialized research, diagnostic, and quality-control workflows. As assay portfolios expand and platforms become more automated and easier to use, digital PCR is expected to strengthen its position as a complementary technology within the broader molecular testing ecosystem.

Industrial Impact

Digital PCR is strengthening the molecular testing ecosystem by enabling more reliable quantitative measurements in applications where low target abundance, complex sample backgrounds, and small concentration differences can limit conventional approaches. Its growing use is supporting greater analytical confidence and improved reproducibility across specialized research, testing, and quality-control workflows.

At an industry level, wider adoption of digital PCR is contributing to increased demand for standardized assays, consistent consumable supply, validated workflows, and interoperable data analysis. This is gradually expanding the technology's role from specialized research toward broader translational, biopharmaceutical, and selected clinical applications where precise molecular measurement provides clear analytical value.

Market Segmentation:

Segmentation 1: by Product

  • Systems
  • Consumables (Kits, Assay, and Reagents)
  • Software and Services

Consumables (Kits, Assays, and Reagents) Segment to Dominate the Digital PCR Market (by Product)

Consumables are expected to lead the global digital PCR market because they are required across sample preparation, reaction setup, partitioning, amplification, and target detection. Recurring purchases of kits, assays, reagents, master mixes, primers, probes, cartridges, chips, and workflow-specific consumables are expected to remain a core revenue driver as digital PCR use expands across oncology, infectious disease testing, genetic analysis, liquid biopsy research, transplant monitoring, and biopharmaceutical applications.

Segmentation 2: by Application

  • Clinical and Research Application
  • Environmental Applications
  • Forensic Applications
  • Other Application

Clinical and Research Application Segment to Dominate the Digital PCR Market (by Application)

Clinical and research applications are expected to lead the global digital PCR market, supported by the increasing use of digital PCR in oncology, infectious disease detection, genetic testing, and molecular research. In clinical diagnostics, digital PCR is valued for detecting and quantifying low-abundance nucleic acid targets, including rare mutations and disease-associated genetic variations, while research users apply it for gene expression analysis, copy number variation assessment, rare variant detection, assay validation, and molecular quantification.

Segmentation 3: By End User

  • Academic and Research Institutions
  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharmaceutical and Biopharmaceutical Companies
  • Other End User

Academic and Research Institutions Segment to Dominate the Digital PCR Market (by End User)

Academic and research institutions are expected to lead due to extensive use of digital PCR in molecular biology, genomics, oncology research, infectious disease studies, rare variant detection, copy number variation analysis, assay development, and next-generation sequencing validation. These institutions are often early adopters because they require sensitive and reproducible tools for biomarker discovery, experimental validation, and translational research.

Segmentation 4: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Australia
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa
    • K.S.A.
    • Egypt
    • Rest-of-Middle East and Africa

North America to Dominate the Digital PCR Market (by Region)

North America is expected to lead the global digital PCR market, supported by advanced healthcare infrastructure, strong molecular diagnostics capabilities, significant research and development activity, and increasing adoption of precision medicine. The region has a well-established ecosystem of clinical laboratories, academic research centers, pharmaceutical and biotechnology companies, and reference testing networks that support digital PCR across oncology, infectious disease testing, genetic analysis, transplant monitoring, liquid biopsy research, and other high-sensitivity molecular applications.

Recent Developments in the Digital PCR Market

  • In June 2026, QIAGEN N.V. announced new additions to its QIAcuity digital polymerase chain reaction ecosystem to expand gene expression capabilities, broaden assay content, and improve workflow standardization across research and biopharma applications.
  • In July 2025, Bio-Rad Laboratories, Inc. announced the launch of four new Droplet Digital PCR platforms, including the QX Continuum ddPCR system and the QX700 series of ddPCR platforms acquired through its completed acquisition of Stilla Technologies.
  • In July 2025, Bio-Rad Laboratories, Inc. completed the acquisition of Stilla Technologies, a developer of next-generation digital polymerase chain reaction systems. The transaction followed a binding offer made earlier in the year and was intended to expand Bio-Rad's digital PCR capabilities.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Increasing Role of Digital PCR in Personalized Medicine, Oncology, and Rare Disease Diagnostics: The growing use of molecular biomarkers to support patient stratification, treatment selection, disease monitoring, and genetic characterization is increasing demand for highly sensitive and precise nucleic acid quantification. Digital PCR is particularly relevant where low-frequency molecular alterations must be detected and measured reliably, strengthening its adoption across personalized medicine, oncology, and rare disease research and diagnostics.

Market Challenges

High Instrument and Consumable Costs Associated with Digital PCR Platforms: The high capital and recurring operational costs associated with digital PCR platforms continue to limit broader adoption, particularly among small and mid-sized laboratories, academic institutions, public hospitals, and diagnostic centers in price-sensitive markets. In addition to instrument procurement, laboratories incur recurring costs related to platform-specific consumables, reagents, cartridges, nanoplates, droplet-generation materials, assay kits, maintenance, and trained personnel. These costs can make digital PCR less accessible than conventional PCR and quantitative PCR for routine or high-volume testing applications.

Market Opportunities

Expanding Role of Digital PCR in Therapeutic Development and Precision Treatment Planning: The increasing use of molecular biomarkers in drug development, clinical research, and companion diagnostic strategies is creating new opportunities for digital PCR. Pharmaceutical and biotechnology companies can use the technology for biomarker validation, rare variant confirmation, treatment-response assessment, viral vector quantification, and orthogonal validation of sequencing findings. Its ability to generate precise quantitative measurements is expected to support wider use across biomarker-driven drug development and advanced therapeutic programs.

How can this report add value to an organization?

Product/Innovation Strategy: The report helps organizations assess where product innovation is concentrated across droplet-based systems, chip-based systems, consumables, software, and application-specific assays. It supports decisions around platform integration, multiplexing, automation, assay expansion, and workflow simplification.

Growth/Marketing Strategy: The regional, product, application, and end-user analysis can help companies prioritize go-to-market execution across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. It also highlights demand drivers such as personalized medicine, infectious disease testing, cell and gene therapy, and emerging molecular diagnostic markets.

Competitive Strategy: The competitive section supports benchmarking against established and specialized companies active across instruments, consumables, reagents, assay kits, workflow-specific cartridges or chips, droplet- and chip-based platforms, software, and service support. It can help identify where differentiation depends on sensitivity, precision, multiplexing, throughput, usability, validation support, and technical service.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2036 have been considered for the global market size estimation, 2025 has been considered as the base year, and 2026 to 2036 as the forecast period.
  • The scope of the report is based on comprehensive inputs from industry experts across various sectors, including digital PCR system providers, consumables and reagent suppliers, assay and kit manufacturers, software and services providers, pharmaceutical and biotechnology companies, academic and research institutions, clinical and diagnostic laboratories, contract research organizations, public health laboratories, and translational research centers.
  • The market contribution of digital PCR is anticipated to grow steadily in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2024 and FY2025. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The market has been mapped based on the existing digital PCR products and systems, consumables, and services. Key companies with significant offerings in digital PCR have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts and key stakeholders across the life sciences, healthcare, molecular diagnostics, and digital PCR ecosystem, including digital PCR system providers, consumables and reagent suppliers, assay and kit manufacturers, software and services providers, pharmaceutical and biotechnology companies, academic and research institutions, clinical and diagnostic laboratories, contract research organizations, public health laboratories, and translational research centers. Stakeholders have been consulted to validate adoption trends, workflow requirements, technology preferences, application areas, pricing dynamics, competitive positioning, and end-user demand across droplet digital PCR, chip-based digital PCR, and other digital PCR workflows. Respondents, including CEOs, vice presidents, product and marketing directors, commercial heads, research and development heads, translational science leaders, and technology and innovation heads, have been interviewed to obtain and verify both qualitative and quantitative insights for this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The global digital PCR market has been characterized by continued technological advancement, growing clinical and research adoption, and strong competition among molecular diagnostics, life science tools, and analytical technology providers. The competitive environment has been primarily shaped by companies focusing on assay sensitivity, absolute quantification accuracy, workflow efficiency, partitioning performance, multiplexing capability, automation, throughput, and software-enabled data analysis.

The market remains moderately competitive, with established and specialized companies such as Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Standard BioTools Inc., Sysmex Corporation, JETA Molecular BV, and other regional technology providers maintaining competitive positions across different parts of the digital PCR workflow. These companies compete across instruments, consumables and reagents, assay kits, droplet- and chip-based platforms, software, and service support, allowing them to address both research-focused and clinically oriented molecular testing needs.

Product innovation remains a central competitive strategy in the global digital PCR market. Key stakeholders are focusing on improving sensitivity, precision, multiplexing, throughput, assay reproducibility, ease of use, automation, and compatibility with broader molecular testing workflows. At the same time, software and data interpretation tools are becoming increasingly important areas of differentiation, as end users require reliable platforms that can support accurate target quantification, reduce workflow variability, simplify analysis, and improve confidence in low-abundance target detection.

Overall, the competitive landscape in the global digital PCR market is shifting from standalone systems toward workflow-oriented solution ecosystems. Success increasingly depends on a company's ability to deliver high-performance platforms, reliable kits and reagents, application-specific assays, user-friendly software, robust validation support, and responsive technical services across clinical, research, and applied testing environments.

Some prominent names established in this market are:

  • Bio-Rad Laboratories, Inc.
  • Standard BioTools, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Genetron Holdings Limited
  • Precigenome LLC
  • RevoSketch Inc.
  • JN Medsys
  • JETA Molecular BV
  • Sysmex Corporation
  • TargetingOne Corporation
  • RainSure Scientific
  • Pilot Gene Technology (Hangzhou) Co., Ltd.

Table of Contents

Executive Summary

Scope and Definition

1 Global Digital PCR Market: Industry Outlook

  • 1.1 Market Overview and Ecosystem
    • 1.1.1 Workflow of Digital PCR
    • 1.1.2 Comparison of qPCR and dPCR
    • 1.1.3 Technology Roadmap and Evolution
    • 1.1.4 Adoption and Penetration Analysis
    • 1.1.5 Digital PCR in Cell and Gene Therapy
    • 1.1.6 Funding and Investment Landscape
    • 1.1.7 Trends: Current and Future Impact Assessment
      • 1.1.7.1 Impact Analysis
        • 1.1.7.1.1 Complementary Use of Digital PCR with Next-Generation Sequencing Workflows
        • 1.1.7.1.2 Shift toward Rapid, Portable, and Decentralized Digital PCR Workflows
        • 1.1.7.1.3 Rising Product Launches in the Digital PCR Ecosystem
    • 1.1.8 Supply Chain Analysis
    • 1.1.9 Pricing Analysis
    • 1.1.10 Patent Analysis
      • 1.1.10.1 Patent Filing Trend by Region
      • 1.1.10.2 Patent Filing Trend by Country
      • 1.1.10.3 Patent Filing Trend (by Year)
    • 1.1.11 Ongoing Digital PCR Clinical Trials
    • 1.1.12 Regulatory Landscape
      • 1.1.12.1 U.S.
      • 1.1.12.2 European Union
      • 1.1.12.3 Asia-Pacific
        • 1.1.12.3.1 Japan
        • 1.1.12.3.2 China
  • 1.2 Market Dynamics
    • 1.2.1 Market Drivers
      • 1.2.1.1 Increasing Role of Digital PCR in Personalized Medicine, Oncology, and Rare Disease Diagnostics
      • 1.2.1.2 Increasing Burden of Infectious Diseases and Need for Rapid Molecular Diagnostics
    • 1.2.2 Market Restraints
      • 1.2.2.1 High Instrument and Consumable Costs Associated with Digital PCR Platforms
      • 1.2.2.2 Shortage of Skilled Molecular Laboratory Professionals and Trained Technicians
    • 1.2.3 Market Opportunities
      • 1.2.3.1 Expanding Role of Digital PCR in Therapeutic Development and Precision Treatment Planning
      • 1.2.3.2 Expanding Digital PCR Adoption in Emerging Molecular Diagnostic Markets

2 Global Digital PCR Market (by Product), $Million, 2024-2036

  • 2.1 Systems
    • 2.1.1 Overview
    • 2.1.2 Market Sizing and Forecast
      • 2.1.2.1 Droplet Digital PCR Systems
      • 2.1.2.2 Chip-Based Digital PCR Systems
  • 2.2 Consumables (Kits, Assays, and Reagents)
    • 2.2.1 Overview
    • 2.2.2 Market Sizing and Forecast
  • 2.3 Software and Services
    • 2.3.1 Overview
    • 2.3.2 Market Sizing and Forecast

3 Global Digital PCR Market (by Application), $Million, 2024-2036

  • 3.1 Clinical and Research Application
    • 3.1.1 Overview
    • 3.1.2 Market Sizing and Forecast
      • 3.1.2.1 Oncology
        • 3.1.2.1.1 Solid Tumor
        • 3.1.2.1.2 Hematological Malignancies
      • 3.1.2.2 Infectious Diseases
        • 3.1.2.2.1 Respiratory Infections
        • 3.1.2.2.2 Gastrointestinal Infections
        • 3.1.2.2.3 Blood-Borne Viral Infections
        • 3.1.2.2.4 Other Infectious Diseases
      • 3.1.2.3 Rare Diseases
        • 3.1.2.3.1 Inherited Trait Type
        • 3.1.2.3.2 Acquired Trait Type
      • 3.1.2.4 Reproductive Genetics
        • 3.1.2.4.1 Prenatal Diseases
        • 3.1.2.4.2 Postnatal Diseases
      • 3.1.2.5 Transplant Diagnostics
      • 3.1.2.6 Other Clinical and Research Applications
  • 3.2 Environmental Applications
    • 3.2.1 Overview
    • 3.2.2 Market Sizing and Forecast
  • 3.3 Forensic Applications
    • 3.3.1 Overview
    • 3.3.2 Market Sizing and Forecast
  • 3.4 Other Applications
    • 3.4.1 Overview
    • 3.4.2 Market Sizing and Forecast

4 Global Digital PCR Market (by End User), $Million, 2024-2036

  • 4.1 Academic and Research Institutions
    • 4.1.1 Overview
    • 4.1.2 Market Sizing and Forecast
  • 4.2 Hospitals and Clinics
    • 4.2.1 Overview
    • 4.2.2 Market Sizing and Forecast
  • 4.3 Diagnostic Centers
    • 4.3.1 Overview
    • 4.3.2 Market Sizing and Forecast
  • 4.4 Pharmaceutical and Biopharmaceutical Companies
    • 4.4.1 Overview
    • 4.4.2 Market Sizing and Forecast
  • 4.5 Other End Users
    • 4.5.1 Overview
    • 4.5.2 Market Sizing and Forecast

5 Global Digital PCR Market (by Region), $Million, 2024-2036

  • 5.1 Regional Summary
  • 5.2 North America
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 Analyst View
    • 5.2.5 Market Sizing and Forecast
      • 5.2.5.1 North America Digital PCR Market, by Product
      • 5.2.5.2 North America Digital PCR Market, by Application
      • 5.2.5.3 North America Digital PCR Market, by End User
      • 5.2.5.4 North America Digital PCR Market, by Country
        • 5.2.5.4.1 U.S.
        • 5.2.5.4.2 Canada
  • 5.3 Europe
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Analyst View
    • 5.3.5 Market Sizing and Forecast
      • 5.3.5.1 Europe Digital PCR Market, by Product
      • 5.3.5.2 Europe Digital PCR Market, by Application
      • 5.3.5.3 Europe Digital PCR Market, by End User
      • 5.3.5.4 Europe Digital PCR Market, by Country
        • 5.3.5.4.1 Germany
        • 5.3.5.4.2 France
        • 5.3.5.4.3 U.K.
        • 5.3.5.4.4 Italy
        • 5.3.5.4.5 Spain
        • 5.3.5.4.6 Rest-of-Europe
  • 5.4 Asia-Pacific
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market
    • 5.4.4 Analyst View
    • 5.4.5 Market Sizing and Forecast
      • 5.4.5.1 Asia-Pacific Digital PCR Market, by Product
      • 5.4.5.2 Asia-Pacific Digital PCR Market, by Application
      • 5.4.5.3 Asia-Pacific Digital PCR Market, by End User
      • 5.4.5.4 Asia-Pacific Digital PCR Market, by Country
        • 5.4.5.4.1 Japan
        • 5.4.5.4.2 China
        • 5.4.5.4.3 Australia
        • 5.4.5.4.4 South Korea
        • 5.4.5.4.5 Rest-of-Asia-Pacific
  • 5.5 Latin America
    • 5.5.1 Regional Overview
    • 5.5.2 Driving Factors for Market Growth
    • 5.5.3 Factors Challenging the Market
    • 5.5.4 Analyst View
    • 5.5.5 Market Sizing and Forecast
      • 5.5.5.1 Latin America Digital PCR Market, by Product
      • 5.5.5.2 Latin America Digital PCR Market, by Application
      • 5.5.5.3 Latin America Digital PCR Market, by End User
      • 5.5.5.4 Latin America Digital PCR Market, by Country
        • 5.5.5.4.1 Brazil
        • 5.5.5.4.2 Mexico
        • 5.5.5.4.3 Rest-of-Latin America
  • 5.6 Middle East and Africa
    • 5.6.1 Regional Overview
    • 5.6.2 Driving Factors for Market Growth
    • 5.6.3 Factors Challenging the Market
    • 5.6.4 Analyst View
    • 5.6.5 Market Sizing and Forecast
      • 5.6.5.1 Middle East and Africa Digital PCR Market, by Product
      • 5.6.5.2 Middle East and Africa Digital PCR Market, by Application
      • 5.6.5.3 Middle East and Africa Digital PCR Market, by End User
      • 5.6.5.4 Middle East and Africa Digital PCR Market, by Country
        • 5.6.5.4.1 K.S.A.
        • 5.6.5.4.2 Egypt
        • 5.6.5.4.3 Rest-of-Middle East and Africa

6 Competitive Benchmarking and Company Profiles

  • 6.1 Key Strategies and Developments
    • 6.1.1 Mergers and Acquisitions
    • 6.1.2 Partnership, Alliances, and Business Expansion
    • 6.1.3 New Offerings
  • 6.2 Company Profiles
    • 6.2.1 Bio-Rad Laboratories, Inc.
      • 6.2.1.1 Overview
      • 6.2.1.2 Top Products/Product Portfolio
      • 6.2.1.3 Target Customers/End-User
      • 6.2.1.4 Key Personnel
      • 6.2.1.5 Analyst View
    • 6.2.2 Standard BioTools, Inc.
      • 6.2.2.1 Overview
      • 6.2.2.2 Top Products/Product Portfolio
      • 6.2.2.3 Target Customers/End-User
      • 6.2.2.4 Key Personnel
      • 6.2.2.5 Analyst View
    • 6.2.3 F. Hoffmann-La Roche Ltd.
      • 6.2.3.1 Overview
      • 6.2.3.2 Top Products/Product Portfolio
      • 6.2.3.3 Target Customers/End-User
      • 6.2.3.4 Key Personnel
      • 6.2.3.5 Analyst View
    • 6.2.4 Merck KGaA
      • 6.2.4.1 Overview
      • 6.2.4.2 Top Products/Product Portfolio
      • 6.2.4.3 Target Customers/End-User
      • 6.2.4.4 Key Personnel
      • 6.2.4.5 Analyst View
    • 6.2.5 QIAGEN N.V.
      • 6.2.5.1 Overview
      • 6.2.5.2 Top Products/Product Portfolio
      • 6.2.5.3 Target Customers/End-User
      • 6.2.5.4 Key Personnel
      • 6.2.5.5 Analyst View
    • 6.2.6 Thermo Fisher Scientific Inc.
      • 6.2.6.1 Overview
      • 6.2.6.2 Top Products/Product Portfolio
      • 6.2.6.3 Target Customers/End-User
      • 6.2.6.4 Key Personnel
      • 6.2.6.5 Analyst View
    • 6.2.7 Genetron Holdings Limited
      • 6.2.7.1 Overview
      • 6.2.7.2 Top Products/Product Portfolio
      • 6.2.7.3 Target Customers/End-User
      • 6.2.7.4 Key Personnel
      • 6.2.7.5 Analyst View
    • 6.2.8 Precigenome LLC
      • 6.2.8.1 Overview
      • 6.2.8.2 Top Products/Product Portfolio
      • 6.2.8.3 Target Customers/End-User
      • 6.2.8.4 Key Personnel
      • 6.2.8.5 Analyst View
    • 6.2.9 RevoSketch Inc.
      • 6.2.9.1 Overview
      • 6.2.9.2 Top Products/Product Portfolio
      • 6.2.9.3 Target Customers/End-User
      • 6.2.9.4 Key Personnel
      • 6.2.9.5 Analyst View
    • 6.2.10 JN Medsys
      • 6.2.10.1 Overview
      • 6.2.10.2 Top Products/Product Portfolio
      • 6.2.10.3 Target Customers/End-User
      • 6.2.10.4 Key Personnel
      • 6.2.10.5 Analyst View
    • 6.2.11 JETA Molecular BV.
      • 6.2.11.1 Overview
      • 6.2.11.2 Top Products/Product Portfolio
      • 6.2.11.3 Target Customers/End-User
      • 6.2.11.4 Key Personnel
      • 6.2.11.5 Analyst View
    • 6.2.12 Sysmex Corporation
      • 6.2.12.1 Overview
      • 6.2.12.2 Top Products/Product Portfolio
      • 6.2.12.3 Target Customers/End-User
      • 6.2.12.4 Key Personnel
      • 6.2.12.5 Analyst View
    • 6.2.13 TargetingOne Corporation
      • 6.2.13.1 Overview
      • 6.2.13.2 Top Products/Product Portfolio
      • 6.2.13.3 Target Customers/End-User
      • 6.2.13.4 Key Personnel
      • 6.2.13.5 Analyst View
    • 6.2.14 RainSure Scientific
      • 6.2.14.1 Overview
      • 6.2.14.2 Top Products/Product Portfolio
      • 6.2.14.3 Target Customers/End-User
      • 6.2.14.4 Key Personnel
      • 6.2.14.5 Analyst View
    • 6.2.15 Pilot Gene Technology (Hangzhou) Co., Ltd.
      • 6.2.15.1 Overview
      • 6.2.15.2 Top Products/Product Portfolio
      • 6.2.15.3 Target Customers/End-User
      • 6.2.15.4 Key Personnel
      • 6.2.15.5 Analyst View

7 Research Methodology

  • 7.1 Data Sources
    • 7.1.1 Primary Data Sources
    • 7.1.2 Secondary Data Sources
    • 7.1.3 Data Triangulation
  • 7.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Digital PCR Market (by Scenario), $Million, 2026, 2031, and 2036
  • Figure 2: Global Digital PCR Market (by Region), $Million, 2025, 2031, 2036
  • Figure 3: Global Digital PCR Market (by Product), $Million, 2025, 2031, and 2036
  • Figure 4: Global Digital PCR Market (by Application), $Million, 2025, 2031, and 2036
  • Figure 5: Global Digital PCR Market (by End User), $Million, 2025, 2031, and 2036
  • Figure 6: Workflow of Digital PCR
  • Figure 7: Supply Chain and Risks within the Supply Chain
  • Figure 8: Global Digital PCR Market (by Region), January 2020-June 2026
  • Figure 9: Global Digital PCR Market (by Country), January 2020-June 2026
  • Figure 10: Global Digital PCR Market (by Year), January 2020-June 2026
  • Figure 11: Global Digital PCR Market (by Product), $Million, 2025, 2031, and 2036
  • Figure 12: Global Digital PCR Market (Systems), $Million, 2024-2036
  • Figure 13: Global Digital PCR Market (Droplet Digital PCR Systems), $Million, 2024-2036
  • Figure 14: Global Digital PCR Market (Chip-Based Digital PCR Systems), $Million, 2024-2036
  • Figure 15: Global Digital PCR Market (Consumables (Kits, Assays, and Reagents)), $Million, 2024-2036
  • Figure 16: Global Digital PCR Market (Software and Services), $Million, 2024-2036
  • Figure 17: Global Digital PCR Market (by Application), $Million, 2025, 2031, and 2036
  • Figure 18: Global Digital PCR Market (Clinical and Research Application), $Million, 2024-2036
  • Figure 19: Global Digital PCR Market (Oncology), $Million, 2024-2036
  • Figure 20: Global Digital PCR Market (Solid Tumor), $Million, 2024-2036
  • Figure 21: Global Digital PCR Market (Hematological Malignancies), $Million, 2024-2036
  • Figure 22: Global Digital PCR Market (Infectious Diseases), $Million, 2024-2036
  • Figure 23: Global Digital PCR Market (Respiratory Infections), $Million, 2024-2036
  • Figure 24: Global Digital PCR Market (Gastrointestinal Infections), $Million, 2024-2036
  • Figure 25: Global Digital PCR Market (Blood-Borne Viral Infections), $Million, 2024-2036
  • Figure 26: Global Digital PCR Market (Other Infectious Diseases), $Million, 2024-2036
  • Figure 27: Global Digital PCR Market (Rare Diseases), $Million, 2024-2036
  • Figure 28: Global Digital PCR Market (Inherited Trait Type), $Million, 2024-2036
  • Figure 29: Global Digital PCR Market (Acquired Trait Type), $Million, 2024-2036
  • Figure 30: Global Digital PCR Market (Reproductive Genetics), $Million, 2024-2036
  • Figure 31: Global Digital PCR Market (Prenatal Diseases), $Million, 2024-2036
  • Figure 32: Global Digital PCR Market (Postnatal Diseases), $Million, 2024-2036
  • Figure 33: Global Digital PCR Market (Transplant Diagnostics), $Million, 2024-2036
  • Figure 34: Global Digital PCR Market (Other Clinical and Research Applications), $Million, 2024-2036
  • Figure 35: Global Digital PCR Market (Environmental Applications), $Million, 2024-2036
  • Figure 36: Global Digital PCR Market (Forensic Applications), $Million, 2024-2036
  • Figure 37: Global Digital PCR Market (Other Applications), $Million, 2024-2036
  • Figure 38: Global Digital PCR Market (by End User), $Million, 2025, 2031, and 2036
  • Figure 39: Global Digital PCR Market (Academic and Research Institutions), $Million, 2024-2036
  • Figure 40: Global Digital PCR Market (Hospitals and Clinics), $Million, 2024-2036
  • Figure 41: Global Digital PCR Market (Diagnostic Centers), $Million, 2024-2036
  • Figure 42: Global Digital PCR Market (Pharmaceutical and Biopharmaceutical Companies), $Million, 2024-2036
  • Figure 43: Global Digital PCR Market (Other End Users), $Million, 2024-2036
  • Figure 44: North America Digital PCR Market, $Million, 2024-2036
  • Figure 45: U.S. Digital PCR Market, $Million, 2024-2036
  • Figure 46: Canada Digital PCR Market, $Million, 2024-2036
  • Figure 47: Europe Digital PCR Market, $Million, 2024-2036
  • Figure 48: Germany Digital PCR Market, $Million, 2024-2036
  • Figure 49: France Digital PCR Market, $Million, 2024-2036
  • Figure 50: U.K. Digital PCR Market, $Million, 2024-2036
  • Figure 51: Italy Digital PCR Market, $Million, 2024-2036
  • Figure 52: Spain Digital PCR Market, $Million, 2024-2036
  • Figure 53: Rest-of-Europe Digital PCR Market, $Million, 2024-2036
  • Figure 54: Asia-Pacific Digital PCR Market, $Million, 2024-2036
  • Figure 55: Japan Digital PCR Market, $Million, 2024-2036
  • Figure 56: China Digital PCR Market, $Million, 2024-2036
  • Figure 57: Australia Digital PCR Market, $Million, 2024-2036
  • Figure 58: South Korea Digital PCR Market, $Million, 2024-2036
  • Figure 59: Rest-of-Asia-Pacific Digital PCR Market, $Million, 2024-2036
  • Figure 60: Latin America Digital PCR Market, $Million, 2024-2036
  • Figure 61: Brazil Digital PCR Market, $Million, 2024-2036
  • Figure 62: Mexico Digital PCR Market, $Million, 2024-2036
  • Figure 63: Rest-of-Latin America Digital PCR Market, $Million, 2024-2036
  • Figure 64: Middle East and Africa Digital PCR Market, $Million, 2024-2036
  • Figure 65: K.S.A. Digital PCR Market, $Million, 2024-2036
  • Figure 66: Egypt Digital PCR Market, $Million, 2024-2036
  • Figure 67: Rest-of-Middle East and Africa Digital PCR Market, $Million, 2024-2036
  • Figure 68: Data Triangulation
  • Figure 69: Top-Down and Bottom-Up Approach
  • Figure 70: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Comparative Analysis of Quantitative PCR (qPCR) and Digital PCR (dPCR)
  • Table 3: Adoption and Penetration of Digital PCR (by Application Area)
  • Table 4: Major Funding Activities, January 2021-June 2026
  • Table 5: Key Recent Product Launches, January 2024-June 2026
  • Table 6: Indicative Pricing Structure in the Digital PCR Market
  • Table 7: Some of the Ongoing Digital PCR (dPCR) Clinical Trials
  • Table 8: Regulatory Framework
  • Table 9: Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
  • Table 10: Global Digital PCR Market (by Region), $Million, 2024-2036
  • Table 11: North America Digital PCR Market (by Product), $Million, 2024-2036
  • Table 12: North America Digital PCR Market (by Application), $Million, 2024-2036
  • Table 13: North America Digital PCR Market (by End User), $Million, 2024-2036
  • Table 14: North America Digital PCR Market (by Country), $Million, 2024-2036
  • Table 15: U.S. Digital PCR Market (by Application), $Million, 2024-2036
  • Table 16: U.S. Digital PCR Market (by End User), $Million, 2024-2036
  • Table 17: Canada Digital PCR Market (by Application), $Million, 2024-2036
  • Table 18: Canada Digital PCR Market (by End User), $Million, 2024-2036
  • Table 19: Europe Digital PCR Market (by Product), $Million, 2024-2036
  • Table 20: Europe Digital PCR Market (by Application), $Million, 2024-2036
  • Table 21: Europe Digital PCR Market (by End User), $Million, 2024-2036
  • Table 22: Europe Digital PCR Market (by Country), $Million, 2024-2036
  • Table 23: Germany Digital PCR Market (by Application), $Million, 2024-2036
  • Table 24: Germany Digital PCR Market (by End User), $Million, 2024-2036
  • Table 25: France Digital PCR Market (by Application), $Million, 2024-2036
  • Table 26: France Digital PCR Market (by End User), $Million, 2024-2036
  • Table 27: U.K. Digital PCR Market (by Application), $Million, 2024-2036
  • Table 28: U.K. Digital PCR Market (by End User), $Million, 2024-2036
  • Table 29: Italy Digital PCR Market (by Application), $Million, 2024-2036
  • Table 30: Italy Digital PCR Market (by End User), $Million, 2024-2036
  • Table 31: Spain Digital PCR Market (by Application), $Million, 2024-2036
  • Table 32: Spain Digital PCR Market (by End User), $Million, 2024-2036
  • Table 33: Rest-of-Europe Digital PCR Market (by Application), $Million, 2024-2036
  • Table 34: Rest-of-Europe Digital PCR Market (by End User), $Million, 2024-2036
  • Table 35: Asia-Pacific Digital PCR Market (by Product), $Million, 2024-2036
  • Table 36: Asia-Pacific Digital PCR Market (by Application), $Million, 2024-2036
  • Table 37: Asia-Pacific Digital PCR Market (by End User), $Million, 2024-2036
  • Table 38: Asia-Pacific Digital PCR Market (by Country), $Million, 2024-2036
  • Table 39: Japan Digital PCR Market (by Application), $Million, 2024-2036
  • Table 40: Japan Digital PCR Market (by End User), $Million, 2024-2036
  • Table 41: China Digital PCR Market (by Application), $Million, 2024-2036
  • Table 42: China Digital PCR Market (by End User), $Million, 2024-2036
  • Table 43: Australia Digital PCR Market (by Application), $Million, 2024-2036
  • Table 44: Australia Digital PCR Market (by End User), $Million, 2024-2036
  • Table 45: South Korea Digital PCR Market (by Application), $Million, 2024-2036
  • Table 46: South Korea Digital PCR Market (by End User), $Million, 2024-2036
  • Table 47: Rest-of-Asia-Pacific Digital PCR Market (by Application), $Million, 2024-2036
  • Table 48: Rest-of-Asia-Pacific Digital PCR Market (by End User), $Million, 2024-2036
  • Table 49: Latin America Digital PCR Market (by Product), $Million, 2024-2036
  • Table 50: Latin America Digital PCR Market (by Application), $Million, 2024-2036
  • Table 51: Latin America Digital PCR Market (by End User), $Million, 2024-2036
  • Table 52: Latin America Digital PCR Market (by Country), $Million, 2024-2036
  • Table 53: Brazil Digital PCR Market (by Application), $Million, 2024-2036
  • Table 54: Brazil Digital PCR Market (by End User), $Million, 2024-2036
  • Table 55: Mexico Digital PCR Market (by Application), $Million, 2024-2036
  • Table 56: Mexico Digital PCR Market (by End User), $Million, 2024-2036
  • Table 57: Rest-of-Latin America Digital PCR Market (by Application), $Million, 2024-2036
  • Table 58: Rest-of-Latin America Digital PCR Market (by End User), $Million, 2024-2036
  • Table 59: Middle East and Africa Digital PCR Market (by Product), $Million, 2024-2036
  • Table 60: Middle East and Africa Digital PCR Market (by Application), $Million, 2024-2036
  • Table 61: Middle East and Africa Digital PCR Market (by End User), $Million, 2024-2036
  • Table 62: Middle East and Africa Digital PCR Market (by Country), $Million, 2024-2036
  • Table 63: K.S.A. Digital PCR Market (by Application), $Million, 2024-2036
  • Table 64: K.S.A. Digital PCR Market (by End User), $Million, 2024-2036
  • Table 65: Egypt Digital PCR Market (by Application), $Million, 2024-2036
  • Table 66: Egypt Digital PCR Market (by End User), $Million, 2024-2036
  • Table 67: Rest-of-Middle East and Africa Digital PCR Market (by Application), $Million, 2024-2036
  • Table 68: Rest-of-Middle East and Africa Digital PCR Market (by End User), $Million, 2024-2036
  • Table 69: Some of the Major Key Strategies: Mergers and Acquisitions, January 2020-June 2026
  • Table 70: Some of the Major Key Strategies: Partnership, Alliances, and Business Expansion, January 2020-June 2026
  • Table 71: Some of the Major Key Strategies: New Offerings, January 2020-June 2026